Related Experiment Video
Updated: Jan 5, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Cytomegalovirus-vectored vaccines for HIV and other pathogens
Peter A Barry1,2,3, Jesse D Deere1,2,3, Yujuan Yue2
1Department of Pathology and Laboratory Medicine.
Abstract:
: The use of cytomegalovirus (CMV) as a vaccine vector to express antigens against multiple infectious diseases, including simian immunodeficiency virus, Ebola virus, plasmodium, and mycobacterium tuberculosis, in rhesus macaques has generated extraordinary levels of protective immunity against subsequent pathogenic challenge. Moreover, the mechanisms of immune protection have altered paradigms about viral vector-mediated immunity against ectopically expressed vaccine antigens. Further optimization of CMV-vectored vaccines, particularly as this approach moves to human clinical trials will be augmented by a more complete understanding of how CMV engenders mechanisms of immune protection. This review summarizes the particulars of the specific CMV vaccine vector that has been used to date (rhesus CMV strain 68-1) in relation to CMV natural history.
Related Concept Videos
Retroviruses
Microorganisms in Medicine and Therapeutics
Retrovirus Life Cycles
Subviral Agents

